The global craniomaxillofacial devices market value is expected to exceed USD 1.71 billion by 2024 growing at an estimated CAGR of over 6.7% from 2016 to 2024. The increasing demand for minimally-invasive procedures for limiting the size of the incision and reducing healing time coupled with rising accidents due to industrialization and urbanization has been the key factor in driving the industry growth.
The rising demand for reconstructive surgery is another key factor boosting the growth of the industry. Growing patient awareness level, growing old people healthcare population base and increase healthcare expenditures are the factors that drive the market revenue.
Organizations like ISCFS and ASCFS are conducting programs to increase awareness pertaining to particular surgery, which helps craniomaxillofacial devices market to rise in future.
There is an increase of adoption of these devices with advanced 3D printed implants in growing reconstructive surgery expected to be a lucrative opportunity in the market. Increase adoption of products like titanium mesh during CMF surgery helps the market to grow.
Based on the surgery location, CMF devices are of internal and external fixators. For manufacturing these devices alloys, polymers, and metals are used. Titanium alloys are used more as metals to manufacture cranial plates due to its low weight, strength, and non-corrosive property.
Polymers such as Medpor and PMMA contained in implants are widely used due to their biocompatible and augmentation of facial and cranial bones. Biomaterials like PPEK and PDLLA are used in resorbable fixation devices.According to the needs of the patient, cranial implants can be manufactured.
Craniomaxillofacial devices are used in applications like dental surgery & orthognathic, ENT & Neurosurgery, and plastic surgery. Furthermore, it is used to reconstruct genetic defects such as down syndrome, treaher Collins syndrome, and cleft syndrome.
These devices are used for treating spinal disorders, deep brain stimulation, dura mater repair, neurovascular diseases, cranial or pelvic trauma and transnasal skull based surgery.
Increasing incident rate of spinal disorder and trauma rate there is a requirement of CMF(Cerebrospinal fluid) during surgery which increases the ENT and neurosurgery market.
The bioabsorbable market is expected to increase over the forecast period, as it rectifies the chances of second surgery required at the time easy assimilation and metallic implants in the body system.
These devices are used in reconstructive surgery and maxillofacial oncologic collectively known as MORS this helps in the widening of craniomaxillofacial devices application.
Owing to the increase of expenditure on cosmetic surgery and demand for aesthetics estimate the growth of plastic surgery to rise in developed economies like U.S.
The industry has been driven by rising investment in R&D facilities to customized implants and insurance coverage through government initiatives under affordable care act.
The craniomaxillofacial devices market on the basis of product type is segmented into bone graft substitutes, CMF distraction, bone graft substitutes, cranial flap fixation thoracic fixation, plate and screw fixation, and temporomandibular joint (TMJ) replacement.
Screw and plate fixation dominated the segment of over 70% revenue share in 2014 due to the increasing usage in surgical procedures such as tumor removal, orthognathic surgery, deformity correction and pediatric surgeries.
The increase of government initiatives for creating awareness in the deformities correction is expected to grow and metallic craniomaxillofacial devices implants with advantages of providing support to structure, less corrosive in nature and higher penetration market comparing to bioabsorbable counterparts.
The restraining factor of craniomaxillofacial devices can be increasing competition, lack of awareness and high surgery cost among the existing patients.
Due to increasing industrialization in North America, there is a rise of facial deformities and fractures which make the market revenue for over 58% globally in 2014.Additionally, due to rising demand for minimally invasive surgeries, technological advancements, high patient awareness levels, and good infrastructure health care helps the growth of the market in North America.
In Europe, CMF represents one of the emerging markets in the orthopedic industry.Five European countries( France,Italy, Germany,UK and Spain), consisting of thoracic fixation, plate and screw fixation, temporomandibular joint (TMJ) replacement, distraction, CMF bone graft substitutes, and cranial flap fixation is estimated to be over $227m in 2013.
In Asia, pacific due to the improving healthcare infrastructure, the presence of opportunities, rising patient awareness levels and economic development are key impact showing drivers to increase the opportunities in Asia pacific.
Key market players of the craniomaxillofacial devices include Medtronic Inc., Boston Medical Products Inc., KLS Martin L.P., TMJ Concepts, Aesculap, Medartis AG,Zimmer-Biomet Inc., Johnson & Johnson (DePuy Synthes), Kanghui Medical Innovation Co. Ltd., Stryker Corp., Gore Medical, Integra LifeSciences and OsteoMed.
The market players are involved in improving their strategic initiatives to improve & increase the product penetration by introducing technologically advanced products in the market. As a strategic move, Aesculap implant system company introduced Pro space in January 2015 a highly osteoconductive and stable for an interbody fusion procedure.
